Improving Adherence to Pharmacological Treatment

Completed · Not applicable

Conditions studied: Medication Adherence

In brief

The overall goal of this study was to implement and evaluate the effects of a systems-based and pharmacist-mediated program designed to improve adherence for patients with known coronary heart disease (CHD) to lipid-lowering pharmacologic therapy and of their physicians/nurse practitioners to the National Cholesterol Education Program Guidelines.

Key facts

Study ID

NCT00848224

Run by

University of Massachusetts, Worcester

People needed

689

Starts

2000-09-01

Expected to finish

2005-05-01

Last updated by the study team

2009-02-20

Who can join

Age: 30 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• was between 30 and 85 years of age;
• had known CHD, defined as the presence of at least one coronary lesion at coronary angiography of >50%.

You may not qualify if…

• was unable or unwilling to give informed consent;
• had a history of intolerance to two or more statin drugs;
• planned to move out of the area within one year of recruitment;
• had a poor prognosis such that life expectancy was thought to be <5 years;
• had a psychiatric illness which limited ability to participate; or
• had no telephone.

Where it is running

• UMass Memorial Medical Center — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.